Severe Parvovirus B19–Associated Myocarditis in Children in the Post–COVID-19 Era: A Multicenter Observational Cohort Study - Top-Institutions - MDSpire

Severe Parvovirus B19–Associated Myocarditis in Children in the Post–COVID-19 Era: A Multicenter Observational Cohort Study

  • By

  • Neal Russell

  • James Hatcher

  • Tim Best

  • Judith Breuer

  • James Charlesworth

  • Peter Muir

  • Barry Vipond

  • Stephane Paulus

  • Rohit Saxena

  • Jacob Simmonds

  • Stefania Vergnano

  • Peter Davis

  • Seilesh Kadambari

  • April 11, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Great Ormond Street Hospital for Children
    Great Ormond Street Hospital for Children

    London, England

    Key Differentiators

    • Pediatric Cardiology
    • Pediatric Infectious Diseases
    • Pediatric Intensive Care

  • #2

    Bristol Royal Hospital for Children
    Bristol Royal Hospital for Children

    Bristol, England

    Key Differentiators

    • Pediatric Cardiology
    • Pediatric Infectious Diseases

  • #3

    John Radcliffe Hospital
    John Radcliffe Hospital

    Oxford, England

    Key Differentiators

    • Pediatric Cardiology
    • Pediatric Infectious Diseases

  • #4

    Children’s Hospital of Philadelphia (CHOP)
    Children’s Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Cardiology
    • Pediatric Infectious Diseases
    • Pediatric Critical Care

  • #5

    Boston Children’s Hospital
    Boston Children’s Hospital

    Boston, MA

    Key Differentiators

    • Pediatric Cardiology
    • Pediatric Infectious Diseases

Original Source(s)

Severe Parvovirus B19–Associated Myocarditis in Children in the Post–COVID-19 Era: A Multicenter Observational Cohort Study

  • by Neal Russell, James Hatcher, Tim Best, Judith Breuer, James Charlesworth, Peter Muir, Barry Vipond, Stephane Paulus, Rohit Saxena, Jacob Simmonds, Stefania Vergnano, Peter Davis, Seilesh Kadambari

  • April 11, 2025

Related Content

Dynamic hyperinflammatory response assessment using HIC scores in COVID-19: application to a large series of patients receiving anakinra

Antibiotic Falls Short in Disc-Related Back Pain

A randomized trial found no greater pain reduction vs placebo, but questions remain about patients with type 1 Modic changes.

Assessing PEPFAR’s Economic and Educational Spillover Effects: An Update